Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

Science

Volumn 334, Issue 6062, 2011, Pages 1573-1577

  Michaud, Mickaël ^a,b,c   Martins, Isabelle ^a,b,c   Sukkurwala, Abdul Qader ^a,b,c   Adjemian, Sandy ^a,b,c   Ma, Yuting ^b,c,d,e   Pellegatti, Patrizia ^f   Shen, Si ^a,b,c   Kepp, Oliver ^a,b,c   Scoazec, Marie ^b   Mignot, Grégoire ^b   Rello Varona, Santiago ^a,b,c   Tailler, Maximilien ^a,b,c   Menger, Laurie ^a,b,c   Vacchelli, Erika ^a,b,c   Galluzzi, Lorenzo ^a,b,c   Ghiringhelli, François ^g,h   Di Virgilio, Francesco ^f   Zitvogel, Laurence ^b,c,d,e   Kroemer, Guido ^a,b,i,j,k  

^a Institut Gustave Roussy   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d University Paris XI   (France)

^e Center of Clinical Investigations in Biotherapies of Cancer CICBT 507   (France)

^f UNIVERSITY OF FERRARA   (Italy)

^g Georges Francois Leclerc Center   (France)

^h UNIVERSITÉ DE BOURGOGNE   (France)

ⁱ CENTRE DE RECHERCHE DES CORDELIERS   (France)

^j HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^k UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYCHLOROQUINE; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; BAFILOMYCIN A1; HYDROXYCHLOROQUINE; MITOXANTRONE; OXALIPLATIN; RAPAMYCIN; UNCLASSIFIED DRUG;

BIODEGRADATION; CANCER; CELL ORGANELLE; CHEMOTHERAPY; CONCENTRATION (COMPOSITION); ENZYME ACTIVITY; IMMUNE RESPONSE; INHIBITION; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; CANCER CHEMOTHERAPY; CELL DEATH; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; EMBRYO; ENZYME DEGRADATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT RESPONSE; TUMOR CELL; TUMOR IMMUNITY;

EID: 83755181759     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1208347     Document Type: Article

References (29)

1. N. Casares et al., J. Exp. Med. 202, 1691 (2005).
2. L. Apetoh et al., Immunol. Rev. 220, 47 (2007).
3. I. Ray-Coquard et al.; European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, Cancer Res. 69, 5383 (2009).
4. F. Ghiringhelli et al., Nat. Med. 15, 1170 (2009).
5. A. Tesniere et al., Oncogene 29, 482 (2010).
6. D. R. Green, T. Ferguson, L. Zitvogel, G. Kroemer, Nat. Rev. Immunol. 9, 353 (2009).
7. R. Zappasodi et al., Cancer Res. 70, 9062 (2010).
8. T. A. Ferguson, J. Choi, D. R. Green, Immunol. Rev. 241, 77 (2011).
9. O. J. Finn, N. Engl. J. Med. 358, 2704 (2008).
10. L. Zitvogel, O. Kepp, G. Kroemer, Nat Rev Clin Oncol 8, 151 (2011).
11. M. Obeid et al., Nat. Med. 13, 54 (2007).
12. S. J. Gardai et al., Cell 123, 321 (2005).
13. M. P. Chao et al., Sci. Transl. Med. 2, 63ra94 (2010).
14. M. E. Bianchi, J. Leukoc. Biol. 86, 573 (2009).
15. C. Mutini et al., J. Immunol. 163, 1958 (1999).
16. T. Panaretakis et al., EMBO J. 28, 578 (2009).
17. B. Levine, N. Mizushima, H. W. Virgin, Nature 469, 323 (2011).
18. P. Pellegatti et al., PLoS ONE 3, e2599 (2008).
19. M. Mandapathil et al., J. Biol. Chem. 285, 7176 (2010).
20. Y. Ma et al., J. Exp. Med. 208, 491 (2011).
21. M. C. Maiuri et al., Cell Death Differ. 16, 87 (2009).
22. R. K. Amaravadi et al., Clin. Cancer Res. 17, 654 (2011).
23. R. Mathew, E. White, Curr. Opin. Genet. Dev. 21, 113 (2011).
24. D. Hanahan, R. A. Weinberg, Cell 144, 646 (2011).
25. V. Karantza-Wadsworth et al., Genes Dev. 21, 1621 (2007).
26. R. Mathew et al., Cell 137, 1062 (2009).
27. A. R. Young et al., Genes Dev. 23, 798 (2009).
28. M. Elgendy, C. Sheridan, G. Brumatti, S. J. Martin, Mol. Cell 42, 23 (2011).
29. A. Fleming, T. Noda, T. Yoshimori, D. C. Rubinsztein, Nat. Chem. Biol. 7, 9 (2011).